ArticleLeukemia2018

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation.

R Chakraborty et al.PubMed ↗Publisher ↗

No numbers read from the abstract.